These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9851223)

  • 41. Synthesis of a carbon-linked mimic of the disaccharide component of the tumor-related SialylTn antigen.
    Abdallah Z; Doisneau G; Beau JM
    Angew Chem Int Ed Engl; 2003 Nov; 42(42):5209-12. PubMed ID: 14601174
    [No Abstract]   [Full Text] [Related]  

  • 42. Structural basis for recognition of breast and colon cancer epitopes Tn antigen and Forssman disaccharide by Helix pomatia lectin.
    Lescar J; Sanchez JF; Audfray A; Coll JL; Breton C; Mitchell EP; Imberty A
    Glycobiology; 2007 Oct; 17(10):1077-83. PubMed ID: 17652409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elucidation of binding specificity of Jacalin toward O-glycosylated peptides: quantitative analysis by frontal affinity chromatography.
    Tachibana K; Nakamura S; Wang H; Iwasaki H; Tachibana K; Maebara K; Cheng L; Hirabayashi J; Narimatsu H
    Glycobiology; 2006 Jan; 16(1):46-53. PubMed ID: 16177266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.
    Lo-Man R; Bay S; Vichier-Guerre S; Dériaud E; Cantacuzène D; Leclerc C
    Cancer Res; 1999 Apr; 59(7):1520-4. PubMed ID: 10197623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration.
    Julien S; Lagadec C; Krzewinski-Recchi MA; Courtand G; Le Bourhis X; Delannoy P
    Breast Cancer Res Treat; 2005 Mar; 90(1):77-84. PubMed ID: 15770530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A carbohydrate vaccine exceeds the sum of its parts.
    Bundle DR
    Nat Chem Biol; 2007 Oct; 3(10):605-6. PubMed ID: 17876314
    [No Abstract]   [Full Text] [Related]  

  • 47. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
    Buskas T; Ingale S; Boons GJ
    Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
    [No Abstract]   [Full Text] [Related]  

  • 48. Protein glycosylation: chaperone mutation in Tn syndrome.
    Ju T; Cummings RD
    Nature; 2005 Oct; 437(7063):1252. PubMed ID: 16251947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Myelodysplastic syndrome with Th-polyagglutination].
    Akahonai Y; Tanimura A; Nakagawa N; Mori M; Kawasaki K; Kobayashi T; Yachi A; Ishii Y
    Rinsho Ketsueki; 1986 Jan; 27(1):54-9. PubMed ID: 3712781
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
    De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR
    J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The solution conformation of C-glycosyl analogues of the sialyl-Tn antigen.
    García-Aparicio V; Malapelle A; Abdallah Z; Doisneau G; Santos JI; Asensio JL; Cañada FJ; Beau JM; Jiménez-Barbero J
    Carbohydr Res; 2007 Sep; 342(12-13):1974-82. PubMed ID: 17466287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tn syndrome].
    Tanaka T; Ueki J
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):582-4. PubMed ID: 9851223
    [No Abstract]   [Full Text] [Related]  

  • 53. The cell-specific expression of glycan antigens exemplified by the deficiency of beta 1,3 galactosyltransferase in the Tn-syndrome.
    Berger EG; Thurnher M; Dinter A
    Transfus Clin Biol; 1994; 1(2):103-8. PubMed ID: 8019643
    [No Abstract]   [Full Text] [Related]  

  • 54. Red cell polyagglutination.
    Levene C; Levene NA; Buskila D; Manny N
    Transfus Med Rev; 1988 Sep; 2(3):176-85. PubMed ID: 2980086
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.